SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-118007
Filing Date
2019-04-25
Accepted
2019-04-25 07:37:01
Documents
8
Period of Report
2019-06-18
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d666807ddef14a.htm DEF 14A 417733
2 GRAPHIC g666807g04o46.jpg GRAPHIC 53774
3 GRAPHIC g666807g11y77.jpg GRAPHIC 26592
4 GRAPHIC g666807g21j11.jpg GRAPHIC 24658
5 GRAPHIC g666807g27h54.jpg GRAPHIC 36548
6 GRAPHIC g666807g34n08.jpg GRAPHIC 43978
7 GRAPHIC g666807g56z83.jpg GRAPHIC 16586
8 GRAPHIC g666807g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-19-118007.txt   729227
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38550 | Film No.: 19765381
SIC: 2836 Biological Products, (No Diagnostic Substances)